Oryzon Genomics S.A. (ORYZF)
OTCMKTS · Delayed Price · Currency is USD
3.600
+0.240 (7.14%)
At close: Jan 27, 2026
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of $286.8 million as of February 12, 2026. Its market cap has increased by 200.83% in one year.
Market Cap
286.80M
Enterprise Value
271.38M
Revenue
8.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.60
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 134.67M to 286.80M, an increase of 112.97%. That is a compound annual growth rate of 7.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 290.97M | 1.06% |
| Dec 31, 2025 | 287.93M | 206.99% |
| Dec 31, 2024 | 93.79M | -21.99% |
| Dec 29, 2023 | 120.23M | -15.47% |
| Dec 30, 2022 | 142.23M | -11.82% |
| Dec 30, 2021 | 161.30M | -37.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |